Universe Pharmaceuticals vs Viatris
UPC and VTRS side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How UPC and VTRS compare
Viatris grew revenue faster over the last twelve months (4.3% versus −22.4% for Universe Pharmaceuticals).
Viatris pays a dividend yielding 2.3%; Universe Pharmaceuticals does not pay one.
Viatris scores higher on the StockData Score (6 against 5 for Universe Pharmaceuticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | UPC | VTRS |
|---|---|---|
| Size and price | ||
| Market cap | – | $23.9B |
| Share price | $1.51 | $20.82 |
| Change, 1 year | −59.0% | 89.1% |
| Change, 5 years | −100.0% | 59.2% |
| Beta (5Y) | 1.06 | 0.86 |
| Employees | 225 | 30K |
| StockData Score | ||
| Total score | 5 | 6 (better) |
| Valuation score | 0 | 2 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 1 (better) | 0 |
| Health score | 2 (better) | 1 |
| Dividend score | 0 | 2 (better) |
| Valuation | ||
| P/S | – | 1.6× |
| EV/EBITDA | – | 12.6× |
| P/FCF | – | 11.3× |
| FCF yield | – | 8.8% |
| Fair value | – | $23.22 |
| Margin of safety | – | 10.4% |
| Growth | ||
| Revenue growth (TTM) | −22.4% | 4.3% (better) |
| Revenue growth, 5Y average | 257% (better) | 3.7% |
| Profitability | ||
| Gross margin | 35.3% | 35.3% (better) |
| Operating margin | −16.3% | −0.03% (better) |
| Net margin | −20.6% | – |
| FCF margin | −29.8% | 14.3% (better) |
| Return on equity | −7261% | – |
| Return on invested capital | −78.0% | – |
| Financial health | ||
| Debt / equity | 0.13 | – |
| Net debt / EBITDA | – | 4.10 |
| Interest coverage | −10.1× | −0.0× (better) |
| Current ratio | 4.05 (better) | 1.55 |
| Altman Z-score | – | 1.21 |
| Piotroski F-score | 4 | – |
| Dividends and buybacks | ||
| Dividend yield | – | 2.3% |
| Years of dividend growth | – | 0 |
| Buyback yield | – | 1.6% |
| Shareholder yield | – | 3.9% |
| Ownership | ||
| Held by institutions | 6.6% | 91.5% |
| Held by insiders | – | 0.36% |
| Insider net buying, 12 months | – | −$1.1M |
| Superinvestors holding | – | 3 |
| Short interest, % of float | – | 3.1% |
Go deeper
- UPC stock overview
- UPC income statement
- UPC valuation and score
- VTRS stock overview
- VTRS income statement
- VTRS valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.